These results will improve our knowledge of AC3, lead to a more comprehensive understanding of the mechanisms underlying the physiological effects of liraglutide on obesity and provide prospects for new therapeutic interventions for human obesity disorders. The gene discussed is ADCY3; the disease is obesity due to melanocortin 4 receptor deficiency.